Results 91 to 100 of about 680 (108)

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

New England Journal of Medicine, 2009
Mitchell N Davis, Mark S Sulkowski
exaly  

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Yilmaz Cakaloglu, Guido Gerken   +2 more
exaly  

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Lancet, The, 2008
Mario Santinami, Alessandro A E Testori, Reinhard Dummer   +2 more
exaly  

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

New England Journal of Medicine, 2002
Michael W Fried, K Rajender Reddy, Dieter Häussinger   +2 more
exaly  

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

New England Journal of Medicine, 2018
Angela Schulz, Nicola Specchio, Emily De Los Reyes   +2 more
exaly  

Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease

New England Journal of Medicine, 2006
Huiman Barnhart
exaly  

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

New England Journal of Medicine, 2007
Janice P Dutcher, Anil Kapoor, David F Mcdermott   +2 more
exaly  

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

New England Journal of Medicine, 2000
Edward Gane, Moises Diago
exaly  

Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa

New England Journal of Medicine, 2001
Amita K Manatunga, Charles B Nemeroff, Andrew H Miller   +2 more
exaly  

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2014
Michael Manns, Maria Buti, Ewa Janczewska   +2 more
exaly